Neonatal Hyperbilirubinemia Phototherapy/Exchange (AAP 2022 Framework) — free guideline decision tool
This decision framework operationalizes the AAP 2022 hyperbilirubinemia guideline: it selects the correct threshold curve by gestational age, hours of age and neurotoxicity risk, then applies phototherapy, escalation and exchange logic.
Open guideline tool →Guideline-based
Implements the decision logic from published clinical guidelines.
Runs in your browser
No installation. Enter the patient's values and get a guideline recommendation instantly.
Data stays local
Nothing is uploaded. Results are for licensed clinicians only.
Common questions
What does Neonatal Hyperbilirubinemia Phototherapy/Exchange (AAP 2022 Framework) do?
Use in newborns ≥ 35 weeks with hyperbilirubinemia to choose the right nomogram and structure phototherapy versus exchange decisions.
How is the result calculated?
Select curve by GA + hours of age + neurotoxicity risk factors. TSB ≥ phototherapy threshold → intensive phototherapy; TSB ≥ (exchange threshold − 2 mg/dL) → escalation of care (medical emergency); TSB ≥ exchange threshold or acute bilirubin encephalopathy → exchange transfusion. Exact thresholds from the official nomogram.
Is this a substitute for clinical judgement?
No. All results are decision-support only, for licensed clinicians. They must be individualized to the whole patient and the latest guideline version.
Run Neonatal Hyperbilirubinemia Phototherapy/Exchange (AAP 2022 Framework) now
This decision framework operationalizes the AAP 2022 hyperbilirubinemia guideline: it selects the correct threshold curve by gestational age, hours of age and neurotoxicity risk, then applies phototherapy, escalation and exchange logic.
Open guideline tool →For licensed clinicians. Not a substitute for clinical judgement.